These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 10563825)

  • 1. Species-specific inhibition of inosine 5'-monophosphate dehydrogenase by mycophenolic acid.
    Digits JA; Hedstrom L
    Biochemistry; 1999 Nov; 38(46):15388-97. PubMed ID: 10563825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic mechanism of Tritrichomonas foetus inosine 5'-monophosphate dehydrogenase.
    Digits JA; Hedstrom L
    Biochemistry; 1999 Feb; 38(8):2295-306. PubMed ID: 10029522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substitution of the conserved Arg-Tyr dyad selectively disrupts the hydrolysis phase of the IMP dehydrogenase reaction.
    Guillén Schlippe YV; Riera TV; Seyedsayamdost MR; Hedstrom L
    Biochemistry; 2004 Apr; 43(15):4511-21. PubMed ID: 15078097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of a ternary complex of Tritrichomonas foetus inosine 5'-monophosphate dehydrogenase: NAD+ orients the active site loop for catalysis.
    Gan L; Petsko GA; Hedstrom L
    Biochemistry; 2002 Nov; 41(44):13309-17. PubMed ID: 12403633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug selectivity is determined by coupling across the NAD+ site of IMP dehydrogenase.
    Digits JA; Hedstrom L
    Biochemistry; 2000 Feb; 39(7):1771-7. PubMed ID: 10677226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycophenolic acid and thiazole adenine dinucleotide inhibition of Tritrichomonas foetus inosine 5'-monophosphate dehydrogenase: implications on enzyme mechanism.
    Hedstrom L; Wang CC
    Biochemistry; 1990 Jan; 29(4):849-54. PubMed ID: 1971185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structures of Tritrichomonasfoetus inosine monophosphate dehydrogenase in complex with substrate, cofactor and analogs: a structural basis for the random-in ordered-out kinetic mechanism.
    Prosise GL; Luecke H
    J Mol Biol; 2003 Feb; 326(2):517-27. PubMed ID: 12559919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IMP dehydrogenase: mechanism of action and inhibition.
    Hedstrom L
    Curr Med Chem; 1999 Jul; 6(7):545-60. PubMed ID: 10390600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic mechanism of human inosine 5'-monophosphate dehydrogenase type II: random addition of substrates and ordered release of products.
    Wang W; Hedstrom L
    Biochemistry; 1997 Jul; 36(28):8479-83. PubMed ID: 9214292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acid-base catalysis in the chemical mechanism of inosine monophosphate dehydrogenase.
    Markham GD; Bock CL; Schalk-Hihi C
    Biochemistry; 1999 Apr; 38(14):4433-40. PubMed ID: 10194364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and characterization of mycophenolic acid-resistant mutants of inosine-5'-monophosphate dehydrogenase.
    Farazi T; Leichman J; Harris T; Cahoon M; Hedstrom L
    J Biol Chem; 1997 Jan; 272(2):961-5. PubMed ID: 8995388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of IMPDH by mycophenolic acid: dissection of forward and reverse pathways using capillary electrophoresis.
    Fleming MA; Chambers SP; Connelly PR; Nimmesgern E; Fox T; Bruzzese FJ; Hoe ST; Fulghum JR; Livingston DJ; Stuver CM; Sintchak MD; Wilson KP; Thomson JA
    Biochemistry; 1996 Jun; 35(22):6990-7. PubMed ID: 8679523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of Tritrichomonas foetus inosine monophosphate dehydrogenase in complex with the inhibitor ribavirin monophosphate reveals a catalysis-dependent ion-binding site.
    Prosise GL; Wu JZ; Luecke H
    J Biol Chem; 2002 Dec; 277(52):50654-9. PubMed ID: 12235158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetically controlled drug resistance: how Penicillium brevicompactum survives mycophenolic acid.
    Sun XE; Hansen BG; Hedstrom L
    J Biol Chem; 2011 Nov; 286(47):40595-600. PubMed ID: 21979957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacillus anthracis inosine 5'-monophosphate dehydrogenase in action: the first bacterial series of structures of phosphate ion-, substrate-, and product-bound complexes.
    Makowska-Grzyska M; Kim Y; Wu R; Wilton R; Gollapalli DR; Wang XK; Zhang R; Jedrzejczak R; Mack JC; Maltseva N; Mulligan R; Binkowski TA; Gornicki P; Kuhn ML; Anderson WF; Hedstrom L; Joachimiak A
    Biochemistry; 2012 Aug; 51(31):6148-63. PubMed ID: 22788966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the IMP binding site in the IMP dehydrogenase from Tritrichomonas foetus.
    Huete-Pérez JA; Wu JC; Whitby FG; Wang CC
    Biochemistry; 1995 Oct; 34(42):13889-94. PubMed ID: 7577983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of inosine 5'-monophosphate dehydrogenase by the antiviral agent 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide 5'-monophosphate.
    Wang W; Papov VV; Minakawa N; Matsuda A; Biemann K; Hedstrom L
    Biochemistry; 1996 Jan; 35(1):95-101. PubMed ID: 8555204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The structure of inosine 5'-monophosphate dehydrogenase and the design of novel inhibitors.
    Sintchak MD; Nimmesgern E
    Immunopharmacology; 2000 May; 47(2-3):163-84. PubMed ID: 10878288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IMP dehydrogenase: the dynamics of drug selectivity.
    Hedstrom L; Gan L; Schlippe YG; Riera T; Seyedsayamdost M
    Nucleic Acids Res Suppl; 2003; (3):97-8. PubMed ID: 14510398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mutational analysis of the active site of human type II inosine 5'-monophosphate dehydrogenase.
    Futer O; Sintchak MD; Caron PR; Nimmesgern E; DeCenzo MT; Livingston DJ; Raybuck SA
    Biochim Biophys Acta; 2002 Jan; 1594(1):27-39. PubMed ID: 11825606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.